231 related articles for article (PubMed ID: 30132259)
1. Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.
Bell J; Belackova V; Lintzeris N
Drugs; 2018 Sep; 78(13):1339-1352. PubMed ID: 30132259
[TBL] [Abstract][Full Text] [Related]
2. Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia's responses to opioid misuse?
Belackova V; Salmon AM; Jauncey M; Bell J
Int J Drug Policy; 2019 Sep; 71():164-168. PubMed ID: 30975592
[TBL] [Abstract][Full Text] [Related]
3. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
[TBL] [Abstract][Full Text] [Related]
6. Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency.
Marchand KI; Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Schechter MT
BMC Health Serv Res; 2011 Jul; 11():174. PubMed ID: 21791093
[TBL] [Abstract][Full Text] [Related]
7. Slow-release oral morphine as maintenance therapy for opioid dependence.
Ferri M; Minozzi S; Bo A; Amato L
Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial.
Marsden J; Stillwell G; Hellier J; Brown AM; Byford S; Kelleher M; Kelly J; Murphy C; Shearer J; Mitcheson L
Contemp Clin Trials; 2017 Feb; 53():36-43. PubMed ID: 27940188
[TBL] [Abstract][Full Text] [Related]
9. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
10. Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.
Fairbairn N; Ross J; Trew M; Meador K; Turnbull J; MacDonald S; Oviedo-Joekes E; Le Foll B; Goyer MÈ; Perreault M; Sutherland C
CMAJ; 2019 Sep; 191(38):E1049-E1056. PubMed ID: 31548191
[No Abstract] [Full Text] [Related]
11. Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
Palis H; Marchand K; Guh D; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT; Oviedo-Joekes E
Subst Abuse Treat Prev Policy; 2017 May; 12(1):25. PubMed ID: 28526048
[TBL] [Abstract][Full Text] [Related]
12. Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.
Oviedo-Joekes E; Brissette S; MacDonald S; Guh D; Marchand K; Jutha S; Harrison S; Janmohamed A; Zhang DZ; Anis AH; Krausz M; Marsh DC; Schechter MT
Drug Alcohol Depend; 2017 Jul; 176():55-62. PubMed ID: 28521199
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
Strang J; Marsden J; Cummins M; Farrell M; Finch E; Gossop M; Stewart D; Welch S
Addiction; 2000 Nov; 95(11):1631-45. PubMed ID: 11219367
[TBL] [Abstract][Full Text] [Related]
14. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review.
McNair R; Monaghan M; Montgomery P
Drug Alcohol Depend; 2023 Jun; 247():109869. PubMed ID: 37086659
[TBL] [Abstract][Full Text] [Related]
15. Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series.
Vogel M; Köck P; Strasser J; Kalbermatten C; Binder H; Dürsteler KM; Walter M; Falcato L; Krausz M; Kormann A
Eur Addict Res; 2022; 28(1):80-86. PubMed ID: 34311466
[TBL] [Abstract][Full Text] [Related]
16. Short term health-related quality of life improvement during opioid agonist treatment.
Nosyk B; Bray JW; Wittenberg E; Aden B; Eggman AA; Weiss RD; Potter J; Ang A; Hser YI; Ling W; Schackman BR
Drug Alcohol Depend; 2015 Dec; 157():121-8. PubMed ID: 26511766
[TBL] [Abstract][Full Text] [Related]
17. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics.
Groshkova T; Metrebian N; Hallam C; Charles V; Martin A; Forzisi L; Lintzeris N; Strang J
Drug Alcohol Rev; 2013 Nov; 32(6):566-73. PubMed ID: 24118500
[TBL] [Abstract][Full Text] [Related]
18. Painkillers fuel growth in drug addiction. Opioid overdoses now kill more people than cocaine or heroin.
Harv Ment Health Lett; 2011 Jan; 27(7):4-5. PubMed ID: 21322902
[No Abstract] [Full Text] [Related]
19. Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities.
Friedmann Z; Kinkel HT; Kühner C; Zsolnai A; Binder A; Mick I
Addict Sci Clin Pract; 2024 May; 19(1):45. PubMed ID: 38802962
[TBL] [Abstract][Full Text] [Related]
20. Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.
Lintzeris N; Strang J; Metrebian N; Byford S; Hallam C; Lee S; Zador D;
Harm Reduct J; 2006 Sep; 3():28. PubMed ID: 17002810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
